We are live on ! Find out more
ACHN

Achillion Pharmaceuticals
ACHN

Delisted

ACHN was delisted on the 27th of January, 2020.

Back to rankings

122 hedge funds and large institutions have $402M invested in Achillion Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 43 increasing their positions, 32 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

127% more call options, than puts

Call options by funds: $1.94M | Put options by funds: $854K

62% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 13

37% more capital invested

Capital invested by funds: $294M → $402M (+$108M)

34% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 32

7% more funds holding

Funds holding: 114 → 122 (+8)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
122
Holders Change
+8
Holders Change %
+7.02%
% of All Funds
2.67%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
43
Reduced
32
Closed
13
Calls
$1.94M
Puts
$854K
Net Calls
+$1.09M
Net Calls Change
+$950K

Top Buyers

Rank Fund Capital Flow
1
BC
Boxer Capital
California
+$7.71M
2
RSCM
Rock Springs Capital Management
Maryland
+$3.37M
3
Renaissance Technologies
Renaissance Technologies
New York
+$3.26M
4
PVI
Pura Vida Investments
New York
+$2.18M
5
UBS Group
UBS Group
Switzerland
+$1.38M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$4.52M
2
Citadel Advisors
Citadel Advisors
Florida
-$4.16M
3
Millennium Management
Millennium Management
New York
-$4.01M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$2.11M
5
Man Group
Man Group
United Kingdom
-$1.86M
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Advisers
26
Two Sigma Advisers
New York
$2.06M +$716K +185,600 +48%
PVI
27
Pura Vida Investments
New York
$2.04M +$2.18M +566,600 New
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$2.04M -$2.11M -548,518 -49%
JP Morgan Chase
29
JP Morgan Chase
New York
$2.01M -$502K -130,257 -19%
QI
30
QS Investors
New York
$1.58M +$2.31K +600 +0.1%
DCM
31
DAFNA Capital Management
California
$1.58M -$640K -166,000 -27%
Citigroup
32
Citigroup
New York
$1.54M +$409K +106,040 +33%
Stifel Financial
33
Stifel Financial
Missouri
$1.44M – – –
Public Sector Pension Investment Board (PSP Investments)
34
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.36M – – –
Morgan Stanley
35
Morgan Stanley
New York
$1.31M -$1.81M -468,677 -56%
Bank of America
36
Bank of America
North Carolina
$1.24M +$58.3K +15,112 +5%
BNP Paribas Financial Markets
37
BNP Paribas Financial Markets
France
$1.14M +$1.16M +299,615 +1,659%
EGI
38
EAM Global Investors
California
$1.03M +$1.1M +285,682 New
KA
39
Kerrisdale Advisers
Florida
$1.02M – – –
AA
40
ALPS Advisors
Colorado
$1M -$45.7K -11,856 -4%
RPAM
41
Rhenman & Partners Asset Management
Sweden
$1M – – –
Squarepoint
42
Squarepoint
New York
$981K +$545K +141,297 +108%
Swiss National Bank
43
Swiss National Bank
Switzerland
$882K – – –
BFM
44
Boothbay Fund Management
New York
$853K +$913K +236,858 New
QIM
45
Quantitative Investment Management
Virginia
$851K +$912K +236,634 New
EI
46
EAM Investors
California
$796K +$852K +221,011 New
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$781K +$71.1K +18,435 +9%
California Public Employees Retirement System
48
California Public Employees Retirement System
California
$773K +$125K +32,404 +18%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$769K +$20.5K +5,330 +3%
State of Wisconsin Investment Board
50
State of Wisconsin Investment Board
Wisconsin
$736K +$69K +17,900 +10%
1
2
3 4 5

ACHN Hedge Fund Activity: Q3 2019 in Review

122 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Achillion Pharmaceuticals (ACHN) for Q3 2019, worth a combined $402M — up 37% from $294M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new ACHN positions and 13 closed out — a net gain of 8 holders — while 43 added to existing stakes and 32 trimmed.

The largest buyer was Boxer Capital, opening a new position worth an estimated $7.71M. The largest seller was State Street, cutting an estimated $4.52M.

  • 122 institutional investors held Achillion Pharmaceuticals (ACHN) as of Q3 2019, up from 114 in Q2 2019.
  • Funds reported $402M of Achillion Pharmaceuticals stock for Q3 2019, up 37% quarter-over-quarter.
  • 21 funds opened new Achillion Pharmaceuticals positions in Q3 2019 and 13 closed out, a net change of +8 holders.
  • The largest Achillion Pharmaceuticals buyer in Q3 2019 was Boxer Capital, an estimated $7.71M added.
  • The largest Achillion Pharmaceuticals seller in Q3 2019 was State Street, an estimated $4.52M sold.

Based on aggregated 13F filings for Q3 2019.